ArticleHemaSphere2022

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study.

Carsten U Niemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.